Tumor cell invasion is a primary event in the metastatic progression of hepatocellular carcinoma (HCC). Our recent results indicate a concordant elevated expression of osteopontin (OPN) and matrix metalloproteinase-9 (MMP-9) in primary metastatic HCC. This study hypothesizes an MMP-9-directed cleavage of OPN that biologically contributes to HCC metastasis. We found that MMP-9 cleaved OPN into specific fragments in vitro, of which three could be identified by Edman degradation amino-acid sequencing. One of these fragments (OPN-5 kDa, residues 167-210) induced low-metastatic HCC cellular invasion via CD44 receptors, which was effectively blocked by the addition of small peptides within the region of OPN-5 kDa. Increased expression of an OPN splice variant (OPN-c) was associated with clinical metastatic HCC. Overexpression of OPN-c with physiological levels of MMP-9 enhanced cellular invasion and coincided with elevated OPN-5 kDa levels. Our data suggest that an alternative splicing event (OPN-c) promotes extracellular cleavage of OPN by MMP-9, thus releasing a distinct region of OPN (OPN-5 kDa) that is essential for HCC cellular invasion and appears to correlate with metastatic potential. The findings of this study may help to improve advanced-stage HCC prognosis and suggest the utility of small peptides for novel therapies.
Introduction
Elucidating the molecular events that promote tumor cell invasion continues to be an important challenge for the treatment and prevention of hepatocellular carcinoma (HCC). HCC is a highly aggressive carcinoma of the liver that is being reported worldwide in increasing numbers (Blum, 2005) . Metastases, especially intrahepatic metastatic recurrences, are the main cause of death in HCC patients who have undergone partial hepatectomy or liver transplantation (Franco et al., 1990; Si et al., 2003) . Identifying the primary contributors to the metastatic cascade, especially at the early stages of cellular invasion, may present opportunities for reducing the severity of this disease through new therapeutic interventions.
Osteopontin (OPN, SPP1) is a secreted multifunctional glycoprotein expressed at high levels in tumors and the surrounding stroma of numerous cancers, including those of the liver (Butler, 1995; Coppola et al., 2004; Rittling and Chambers, 2004) . Increased serum and plasma OPN levels are associated with advanced-stage lung, breast, colon and prostate carcinomas (Singhal et al., 1997; Fedarko et al., 2001; Hotte et al., 2002) . Importantly, OPN expression can predict high-grade, late-stage and early-recurrence HCC (Pan et al., 2003) and is highly correlated with tumor recurrence and decreased patient survival following orthotopic liver transplantation (Wang, 2005) . Previous data from our laboratory demonstrated a correlation between OPN mRNA expression and primary HCC metastasis (Ye et al., 2003) . Cytoplasmic OPN was detected at the leading edge of metastatic HCC and vascularized regions of tumors but was absent in normal liver (Ye et al., 2003) . Furthermore, a neutralizing antibody to OPN can decrease pulmonary metastases in nude mice and inhibit tumor cell invasion, highlighting an essential role of OPN in HCC metastasis (Ye et al., 2003) .
Local and extrahepatic tumor cell invasions are associated with extensive matrix remodeling, angiogenesis and hepatocyte injury in HCC (McKenna et al., 2002) . The members of the zinc-dependent endopeptidase family of matrix metalloproteinases (MMPs) catabolize extracellular matrix components, which are likely to play an active role in these processes (Theret et al., 2001) . Each MMP is classified by substrate activity and contains a catalytic domain, a propeptide regulatory domain and carboxy-terminal (C-terminal) hemopoexin-like structural domains. The gelatinases (matrix metalloproteinase-2 (MMP-2) and MMP-9) play roles in tumor invasion, angiogenesis and cancer progression in several neoplasias (van Kempen and Coussens, 2002; Turpeenniemi-Hujanen, 2005) . Active MMP-9 enzymatically cleaves basement membrane proteins (e.g. collagen types IV, V, VII, X and XIV) and can be detected at the invasive front of HCC (Kaneyoshi et al., 2001) . Previous data from our laboratory indicated that a substantial increase in MMP-9 mRNA occurs in primary metastatic HCC (Ye et al., 2003) , which are consistent with previous correlations between MMP-9 abundance and degree of HCC cellular invasiveness (Ashida et al., 1996; Lin et al., 1998) .
Stromelysin-1 (MMP-3) and matrilysin (MMP-7) are reported to cleave OPN in vitro at residues 166 and 210, generating OPN fragments that increase tumor cell adhesion via cell-surface integrin receptors and peritoneal macrophage migration (Agnihotri et al., 2001) . The thrombin coagulation factor also cleaves OPN at residue 168, resulting in two fragments of similar molecular weight (B 28-30 kDa), which are readily detected in the serum and plasma of patients with cancer (Senger et al., 1988) . Thrombin-cleaved OPN mediates increased adhesion and migration of tumor cells via binding of the amino-terminal reactive Ary-Gly-Asp (RGD) tripeptide motif (residues 159-161) to cell-surface integrins, namely the vitronectin receptor (a5b3); interactions of OPN with a4b1 and a9b1 through the cryptic 'SVVYGLR' motif have also been described (Weber, 2001; Wai and Kuo, 2004) .
The CD44 family are cell-surface adhesion molecules that mediate cell-matrix interactions and have been linked to increased inflammation and metastasis (Ponta et al., 2003) . The CD44 standard isoform is expressed on a diverse group of both normal and malignant cell types and elevated levels are correlated with aggressiveness of some human neoplasms (Rudzki and Jothy, 1997) . Knockdown of CD44 expression reduces tumor growth and metastasis in colon carcinoma cells (Harada et al., 2001) . Protein expression levels of standard and variant isoforms of CD44 are upregulated in poorly differentiated HCC and relate to shortened survival times (Endo and Terada, 2000) . CD44 splice variant expression appears restricted to human cancers and has been proposed as a means to diagnose tumor cell metastatic propensity in breast and colon cancers (Matsumura and Tarin, 1992) . A C-terminal region of OPN (residues 169-300) binds CD44 to mediate cellular chemotaxis (Weber et al., 1997) and a thrombin-cleaved C-terminal OPN fragment induces macrophage migration via CD44 pathways (Weber et al., 2002) .
In this study, we hypothesize a proteolytic cleavage of OPN by MMP-9 that promotes intrahepatic tumor metastasis. Thus, we attempt to investigate the biological function of specific regions of OPN as related to HCC tumor cell invasion. In addition, we functionally test the effects of a variant splicing product of OPN and MMP-9 interaction on cellular invasion. The findings from this study are suggestive of a mechanism by which OPN and MMP-9 function in concert to promote early tumor cell invasion in vivo and evoke a novel peptide approach for HCC treatment.
Results

Coregulated expression of OPN and MMP-9 in HCC
A close examination of our previously published microarray data set indicated a significantly increased expression of OPN and MMP-9 in primary HCC tumors and their secondary metastatic lesions (Ye et al., 2003) (Figure 1a ), which were correlated within each patient case (Figure 1b) . Increased mRNA levels of wild-type OPN (OPN-a) and a splice variant (OPN-c) were detected in metastatic vs non-metastatic HCC of the same cohort used previously (Ye et al., 2003) by quantitative real-time reverse transcription-polymerase chain reaction (RT-PCR) ( Figure 1c) ; interestingly, this effect was notably greater for OPN-c (P ¼ 0.00074 vs P ¼ 0.019). Further, increased OPN-c levels were detected in surrounding non-cancerous tissue of metastatic HCC as compared with non-metastatic HCC samples; however, this difference was not observed for OPN-a (P ¼ 0.030 vs P ¼ 0.15) (data not shown). In addition, greater OPN-c mRNA expression level differences were detected in a highly invasive HCC cell line (MHCC-97) vs low invasive cells (Hep3B and SMMC-7721) (Figure 1d ).
MMP-9 liberates a physiologically relevant 5 kDa fragment of OPN Five MMP-9-generated OPN cleavage products running lower than the undigested 65 kDa recombinant protein and visualized by silver staining were as follows: 45-, 34-, 32-, 24-and 5 kDa (Supplementary Figure 1) . Of these fragments, three could be identified using aminoterminal Edman degradation sequencing (32-, 24-and 5 kDa) with >90% accuracy to 10 residues. From these results, it was deduced that MMP-9 cleaved OPN at two predominant sites in vitro (residues 166 and 210), resulting in four fragments, that is, OPN-34 kDa (residues 1-166), OPN-32 kDa (residues 167-314), OPN-5 kDa (residues 167-210) and OPN-24 kDa (residues 211-314). OPN-32 kDa and OPN-5 kDa were detected with an antibody recognizing residues 169-183 (Figure 2a) . Furthermore, OPN-5 kDa formation appeared to be dependent on cleavage of the intermediate OPN-32 kDa over time (Figure 2a) . OPN-5 kDa could be distinguished from the products of thrombin digestion and was undetected in reactions partially inhibited by the concomitant addition of ethylenediamine tetraaceticacid (EDTA), the natural inhibitor of MMP-9 (tissue inhibitor of MMP-1, TIMP-1), or a hydroxamate MMP-9 inhibitor. Addition of a monoclonal antibody to MMP-9 resulted in a similar degree of inhibition (data not shown).
Relative protein levels of endogenous OPN and the 5 kDa cleavage fragment correlated with the degree of metastatic potential in three human HCC cell lines tested, with the highly invasive cell line MHCC-97 expressing the most prominent levels (2.5-15X greater fold) (Figure 2b and c) . In addition, levels of secreted gelatinases (pro-MMP-9 and pro-MMP-2) were the highest in MHCC-97 cell media as compared with the 
OPN-5 kDa induces cellular invasion via CD44 but not the vitronectin receptor (a5b3)
To test the functional regions of OPN contributing to cellular invasion, truncated expression constructs were generated based on the deduced sites of MMP-9-directed cleavage ( Figure 3a ) and initially tested for expression in human embryonic kidney-293 (HEK-293) cell lysates (Figure 3b ). OPN-5 kDa induced reproducible X2-fold increases in cellular invasion in SMMC-7721 cells (P ¼ 0.001) (Figure 3c ). OPN-a induced a small increase in invasive activity, but not to the extent observed by OPN-5 kDa. An increased invasive activity was not observed with OPN-24 kDa and OPN-34 kDa.
In contrast, addition of a blocking antibody to CD44 inhibited OPN-5 kDa-induced invasion (P ¼ 0.0005), whereas a blocking antibody to the integrin a5b3 receptor had no effect (Figure 3d ). Similar effects on cellular invasion could be observed in the low metastatic Hep3B cell line (data not shown).
Small peptides can inhibit OPN-5 kDa-mediated invasion
A synthetic OPN-5 kDa peptide elicited a similar increase in SMMC-7721 cellular invasion in a dosedependent manner ( Figure 4a ). To further elucidate the minimum region responsible for OPN-5 kDa function, a series of short peptides spanning the region of residues 167-210 were synthesized. Addition of these peptides to Identifying a functional fragment of osteopontin V Takafuji et al SMMC-7721 cells at equal molar concentrations did not increase cellular invasion as compared with OPN-5 kDa or a control peptide known not to bind cell surface receptors (GRADSP). However, three peptides (p3 ¼ PDIQYPDATD, p6 ¼ HMESEELNGA and p7 ¼ ELNGAYKAIP) suppressed invasion relative to media-treated cells (Po0.05) (Figure 4b ). Upon separate addition of the three peptides in conjunction with OPN-5 kDa, a partial reduction in invasion was observed (Po0.002), which contrasted the insignificant effect of another peptide, p2 ( Figure 4c) . Interestingly, the combined addition of the three peptides (p3 þ p6 þ p7) further reduced the OPN-5 kDa-mediated response (P ¼ 2 Â 10 À5 ).
OPN-c enhances cellular invasion via the region of OPN-5 kDa
Expression constructs encoding the wild-type protein (OPN-a) and the splice variant (OPN-c) sequences were generated ( Figure 5a ) and initially tested for expression in HEK-293 cell lysates ( Figure 5b ). OPN-a and OPN-c overexpression in SMMC-7721 cells in the presence of condition media resulted in a significant increase in cellular invasion. These responses appeared to be specific for MMP-9-directed activity, since the effect was abolished by the addition of a synthetic inhibitor to MMP-9 ( Figure 5c ). Prominent levels of OPN-5 kDa could be detected in OPN-c-transfected cell lysates ( Figure 5d , left panel) and immunoprecipitated from the culture media using our anti-5 kDa polyclonal antibody ( Figure 5d , right panel), whereas lower OPN-5 kDa levels were detected in OPN-a-transfected cells. Consistently, more OPN-c than OPN-a could be detected in concentrated media derived from SMMC-7721 cells expressing these constructs ( Figure 5d , middle panel). The increased level of invasion observed of OPN-ctransfected cells subjected to physiological MMP-9 levels could be inhibited with addition of anti-CD44, whereas the inhibitory effect on OPN-a-transfected cells was ) to upper chambers of Matrigel-coated 8 mm pore membranes (HTS TM Fluoroblok invasion system, BD Biosciences). After 36 h, invading cells were labeled with calcein AM (371C, 1 h) and measured (EX 485 , EM 530 ). Data were presented as percent cell invasion (mean7s.d.) of total cells migrating through uncoated control membranes. (d) HCC cell number adjusted conditioned media was loaded onto a 10% SDS-PAGE gel containing 0.1% gelatin and compared to MMP-9 and MMP-2 standards (0.5 mg).
Identifying a functional fragment of osteopontin V Takafuji et al not as pronounced (P ¼ 0.011 vs P ¼ 0.055) (Figure 5e ). Taken together, these results suggest that OPN-c is more soluble than OPN-a when secreted and is thus more likely subject to cleavage by MMP-9.
Discussion
Metastasis is a major complication of HCC pathogenesis that typifies a poor prognosis. We have previously identified OPN as a predictive marker for HCC and a molecular target of the HCC metastatic phenotype (Ye et al., 2003) . Importantly, separate elevation of OPN and MMP-9 protein levels in tumors and serum have been found to correlate with the degree of tumor malignancy and metastasis in numerous cancers (Ashida et al., 1996; Singhal et al., 1997; Fedarko et al., 2001) . In this study, we propose an OPN/MMP-9 interaction that is related to intra-hepatic tumor cell invasion in HCC.
We have identified a unique OPN-5 kDa fragment that correlates with metastatic potential in three tested HCC cell lines and induces cellular invasion via CD44 receptors. Exogenous treatment of either recombinant OPN or the OPN-5 kDa peptide (in 50-2000 nM concentrations) did not induce HCC cell line gelatinase or CD44 protein level expression/activity (data not shown), suggesting that the observed effects on cellular invasion are due to OPN-5 kDa function and not fluctuating MMP-9 or CD44 levels. We propose that molecular targeting of OPN-5 kDa could be utilized to improve HCC treatment and prognosis. 
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We first demonstrate that MMP-9 can cleave OPN into at least three sequence-identified fragments in vitro, which is reminiscent of previously reported MMP-3/ MMP-7 cleavage events (Agnihotri et al., 2001 ), but is distinct from thrombin cleavage by generation of a protein fragment running at 5 kDa. Immunoblot analysis using a commercial polyclonal antibody to an OPN sequence downstream of the thrombin cleavage site (residues 169-183) strongly detects the OPN-32 kDa intermediate fragment likely because the relevant epitope is more exposed relative to the full-length native protein; this epitope is lacking in the 34-and 24 kDa fragments and neither could be readily detected by these methods, although some cross-reactivity with the 34 kDa fragment was apparent (Figure 2a ). The addition of various chemical (EDTA, MMP-9 hydroxymate inhibitor) and biological MMP inhibitors (TIMP-1) could partially suppress MMP-9-directed cleavage since the OPN-5 kDa was not detected in these lanes (Figure 2a) . It is possible that further optimization of inhibitor concentration, incubation conditions or inhibitor pretreatment would improve the efficiency of inhibited cleavage. An additional fragment observed by both silver staining and Western blot analysis (OPN-45 kDa) could not be identified by sequencing and its potential biological activity was not further addressed in this study.
We propose that proteolytic exposure of a cryptic non-RGD region of OPN is necessary to mediate cellular invasion, which is independent of a5b3 receptor function. CD44 is a type I transmembrane protein that has been proposed to contribute to cell motility and chemotaxis by forming an adhesive bridge between the extracellular matrix and the intracellular actin cytoskeleton via intracellular domain interactions (Lesley and Hyman, 1998) . The C-terminal region of OPN just downstream of the RGD motif (residues 169-300) has been previously described to bind CD44 to mediate macrophage chemotaxis (Weber, 2001) . Furthermore, OPN has been shown to ligate CD44 and receptor variants (v6 and v7) by RGD-independent mechanisms (Weber et al., 1997; Denhardt et al., 2001) . The results from our study indicate that a more truncated region of essential binding residues (residues 170-210) is important for OPN-mediated haptotactic response in tumor cells. A synthetic peptide corresponding to this fragment induces similar effects, suggesting that protein modifications of this region are not necessary for invasive function. Our data also suggest that the entire 44 residues are required for function because shorter peptides are unable to elicit the same response.
Additional data suggest that the mechanisms directing tumor cell invasion are biologically distinct since overexpression of OPN-5 kDa results in opposite decreased effects on adhesion and migration ( Supplementary  Figures 2-4 ). It is possible that different regions of the OPN protein have divergent functions. This agrees with a previous study, which demonstrated that a C-terminal OPN can suppress fibroblast adhesion mediated by an RGD amino-terminal fragment (Takahashi et al., 1998) . However, we acknowledge that possible contributions of other integrin receptors (i.e. a9b1, a4b1) or CD44 variants (i.e. v6, v3) cannot be ruled out due to the limitations of the blocking antibodies utilized in our study. The OPN-5 kDa peptide and small overlapping peptides spanning the OPN-5 kDa sequence (p1-p8) were added to the upper wells of invasion chambers (2 mM). Data were adjusted to media controls ( ¼ 1). * denotes significance Po0.037. (c) Four peptides: p2, p3, p6 and p7 (2 mM) were added with SMMC-7721 cells to upper invasion chambers in the presence of the OPN-5 kDa peptide (2 mM). A combination of three peptides (p3 þ p6 þ p7) was tested with and without the OPN-5 kDa peptide. * denotes significance Po0.002.
Few studies have investigated alternative splicing of OPN in cancer, except in glioma cell lines (Saitoh et al., 1995) and more recently in breast carcinoma (He et al., 2006) . Our results indicate that greater mRNA expression differences of OPN-c compared with OPN-a occur in metastatic HCC clinical samples; significant differences were not observed for the other currently described variant, OPN-b (data not shown). OPN-c is missing the amino-terminus exon 4 (27 amino acids) that encodes a transglutaminase-reactive domain (Gly-Â -Gly) which Identifying a functional fragment of osteopontin V Takafuji et al mediates covalent homodimer and heterodimer crosslinking to matrix components (i.e. fibronectin) (Prince et al., 1991; Sorensen et al., 1994; Kaartinen et al., 1999) . OPN-c increases MCF-7 breast cancer cell growth in soft agar, whereas stable OPN-a expression results in increased protein aggregation but has no effect on anchorage-independent growth, indicating functional divergence of these splice variants in the context of tumorigenesis (He et al., 2006) .
In this study, overexpression of OPN-c was found to increase CD44-mediated cellular invasion that was enhanced by MMP-9 activity and coincided with increased OPN-5 kDa levels. Conditioned media from macrophage cell cultures was used as a source of MMP-9 to mimic physiological levels of gelatinases in the tumor cell microenvironment. The fact that addition of an MMP-9-specific inhibitor could block the invasive response indicates the crucial role of MMP-9 rather than other proteins and enzymes likely to be present in the media. Further, neutralization of CD44 function appeared to suppress OPN-c-mediated invasion to a greater degree than OPN-a ( Figure 5e ); this observation coupled with higher OPN-5 kDa levels in OPN-ctransfected cell lysates and media supports a potential invasive-promoting function of OPN-5 kDa potentially linked to an alternative splicing event.
Functional divergence between a soluble and matrix-associated OPN has been proposed in tumorigenesis, although OPN isoform abundance is not addressed in this study (Rittling et al., 2002) . Based on the results of the current study, it is possible that OPN splice variant diversity (i.e. increased OPN-c) in different cancers contributes to greater solubility of OPN and susceptibility to MMP-9 cleavage in the tumor cell microenvironment, which in turn results in higher OPN-5 kDa levels and cellular invasiveness. However, this hypothesis remains preliminary and further experiments are warranted to support this as a possible mechanism for the contribution of OPN and MMP-9 to the degree of metastatic propensity in HCC and other cancers.
The results of this study underscore a novel approach to the study and treatment of metastatic HCC. We have identified an MMP-9-liberated, RGD-independent region of OPN, which enhances HCC cellular invasion to a high degree and have used this information to develop a polyclonal antibody of potential use in serological-based diagnoses of HCC. We suggest that the presence of increased OPN-5 kDa in serum samples from metastatic HCC patients may provide diagnostic or prognostic value. In addition, the observed inhibition of tumor cell invasion resulting from short peptide treatment suggests a new therapeutic approach targeted to OPN. Thus, an HCC patient presenting an elevated serum OPN-5 kDa may benefit from the use of these small peptide-based therapies. The use of such strategies may improve the efficacy of targeted approaches to the prevention of HCC metastasis and tumor recurrence. Future efforts will attempt to elucidate the CD44 receptor binding site structures involved for further drug design.
Materials and methods
Cell lines and culture conditions
Human HCC cell lines were analysed for endogenous OPN expression and MMP-9 activity and tested in functional assays following transient OPN transfection as described below. Two low-metastatic cell lines (Hep3B and SMMC-7721) were routinely passaged to B75-80% confluence in minimum essential medium (EMEM) or Rosewell Park Memorial Institute 1640 (RPMI 1640) media, respectively, containing 10% fetal bovine serum (FBS) (Invitrogen, Carlsbad, CA, USA), L-glutamine (2 mM) (Invitrogen) and penicillin sodium (100 U/ml)/streptomycin sulfate (100 mg/ml) (Invitrogen). A high-metastatic HCC cell line MHCC-97 and the murine macrophage cell line ANA-1 were similarly cultured in 10% FBS-supplemented Dulbecco's modified essential medium (DMEM) (Invitrogen) containing L-glutamine and penicillin/ streptomycin. ANA-1 cells were cultured for 72 h to near confluence in DMEM with 10% FBS and re-fed with serumfree media for 36 h before harvest for use in invasion assays as indicated below. HEK-293 cells were cultured in 10% FBSsupplemented EMEM containing L-glutamine and penicillin/ streptomycin.
Eukaryotic and bacterial OPN constructs
The DNA sequences encoding the open reading frame of the mature wild-type OPN protein (GenBank X13694) without a stop codon (OPN-a, base pairs 49-942) and three truncated proteins OPN-34 kDa (base pairs 49-498), OPN-5 kDa (base pairs 499-630) and OPN-24 kDa (base pairs 631-942) were PCR-amplified from a human HCC cell line cDNA template (MHCC-97). The predicted 16-residue OPN signal peptide sequence MRIAVICFCLLGITCA (base pairs 1-48) was fused to the amino-terminus of all constructs following a Kozak eukaryotic translation initiation sequence (5 0 -ACC). The final sequences were flanked by Gateway recombination signal sequences, attB1.1 (5 0 end) and attB2.1 (3 0 end), and recombined into the pDonr223 entry vector using manufacturer protocols (Gateway BP recombination reaction, Invitrogen). Sequence-verified clones were subsequently subcloned using Gateway LR recombination into a cytomegalovirus immediate early proteins (CMV)-promoter mammalian expression vector with a C-terminal FLAG tag (pDest-490). A truncated splice variant OPN-c (base pairs 1-93, 175-942) was generated from the wild-type OPN-a clone using an overlap PCR strategy and similarly transferred to the pDest-490 vector with a C-terminal FLAG tag. The truncated OPN-5 kDa sequence (base pairs 499-630) without the 16-residue signal sequence was similarly cloned into an entry vector and transferred to a T7-promoter bacterial expression vector (pDest-566) containing an amino-terminal 6 Â histidine -maltose binding protein tag and Tev protease site (H6-MBP-tev-OPN-5 kDa). All final expression clones were verified by size and restriction digest patterns.
Transient transfection HEK-293 cells were transfected with 5 mg OPN plasmid DNA using Lipofectamine 2000 (Invitrogen) and lysates were harvested after 24 h for initial immunoblot testing of expression of the various OPN constructs. For all subsequent functional experiments (cellular invasion, adhesion and migration), HCC cells (1 Â 10 6 ) were transfected with 5 mg OPN plasmid DNA using optimized nucleofection conditions (50-60% efficiency by pmaxGFP visualization) (AMAXA, Gaithersburg, MD, USA).
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Invasion and migration assays SMMC-7721 cells were transfected and seeded (5 Â 10 4 ) to upper chambers of Matrigel-coated 8 mm pore membranes (HTS TM Fluoroblok invasion system, BD Biosciences, Bedford, MA, USA) or uncoated 8 mm pore control membranes. Antibodies to integrin a5b3 (clone LM609, Calbiochem, San Diego, CA, USA) or a common determinant of CD44 (clone A020, Chemicon, Temecula, CA, USA) and the hydroxamate MMP-9 inhibitor I (2 mM) (Calbiochem) were added with cells to upper chambers (4 mg/ml). Filter-sterilized medium from a macrophage cell line (ANA-1) containing physiological MMP-9 levels (B200 ng/ml by zymography) was diluted (1:1 volumes) to upper chambers with OPN-a/ OPN-c-transfected cells. Media containing serum (5%) was added to lower chambers as a chemoattractant. After 36 h, invading or migratory cells were detected following calcein acetoxymethyl (AM) staining (37 C, 1 h) (Invitrogen) (EX 485 , EM 530 ).
Adhesion assays SMMC-7721 cells were seeded to 96-well fluorescent-read plates in serum-free media (6 Â 10 4 /well) following transfection. Non-adherent cells were washed with phosphate-buffered saline (PBS) (100 ml) after 2-60 min and adherent cells were quantified following CyQuant GR dye incorporation (Invitrogen) at EX 485 , EM 530 .
OPN cleavage assays
Human MMP-9 (Calbiochem) was incubated with recombinant human OPN (R&D systems, Minneapolis, MN, USA) at a 5:1 substrate:enzyme ratio at 371C for 3 h in a buffered solution (200 mM NaCl, 5 mM CaCl, 50 mM Tris-Cl, pH 7.5). Digested OPN was analysed by 16% tris-glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) followed by colloidal Coomassie blue staining. EDTA (Sigma, St Louis, MO, USA), tissue inhibitor of matrix metalloproteinase, TIMP-1 (Calbiochem) and the hydroxamate MMP-9 inhibitor I (Calbiochem) were added at the start of incubation. Separate cleavage reactions (2 mg OPN) were transferred to polyvinylidene fluoride (PVDF) membranes for amino-end Edman degradation amino-acid sequencing (Protein Chemistry Laboratory, SAIC-Frederick, National Cancer Institute, Frederick, MD, USA).
Western blot analysis and immunoprecipitation
In vitro digested OPN and whole-cell lysates (50 mg) were transferred to PVDF membranes and probed with a polyclonal antibody generated to a 14-residue peptide downstream of the residue 169 thrombin cleavage site (NH 2 -KSKKFRRPDI-QYPD-COOH) (pAb8448, Abcam, Cambridge, MA, USA). Cell lysates were probed with an anti-FLAG antibody (Sigma), our OPN polyclonal antibody, 'anti-5 kDa' (see methods below) or anti-b-actin (mAb1501, Sigma). Immunoprecipitation of conditioned media samples was performed using the anti-5 kDa antibody at B3 mg/ml. Immunoreactive proteins were detected by chemilluminescence (ECL, GE Life Sciences, Piscataway, NJ, USA). To detect OPN in media of transfected SMMC-7721 cells, 5 ml of conditioned media were collected, centrifuged at 1000 r.p.m. for 5 min and filtered through YM-30 Microcon Centrifugal Filter Device (Milipore, Billerica, MA, USA) per manufacturer's instructions to concentrate to a final volume of 100 ml. A 20 ml aliquot of the concentrated media was used for western blotting analysis with anti-5 kDA antibody.
Gelatin zymography
Cell number adjusted serum-free media harvested from HCC cell lines cultured to near-confluence were run on 10% trisglycine gels containing 0.1% gelatin (Invitrogen). Separated proteins were renatured at 251C for 1 h (2.5% Triton X-100), developed at 371C for 16 h (50 mM Tris, 0.2 M NaCl, 5 mM CaCl 2 , 0.02% Brij 35) and stained (0.1% amido black). Pro-MMP-9, active MMP-9 and active MMP-2 standards were included as controls (0.5 mg).
Quantitative RT-PCR RNA samples were previously extracted from hepatic tissues as described (Ye et al., 2003) , including primary metastatic HCC (n ¼ 17), non-metastatic HCC (n ¼ 15) and paired noncancerous tissues collected >2 cm from lesions. RNA extracted from eight normal liver tissues was used as a reference pool. RNA was quality assessed before reverse transcription (10 mg) (cDNA archive kit, Applied Biosystems, Foster City, CA, USA) and 100 ng converted cDNA was used for each reaction. 
Peptide generation
The 44-residue OPN-5 kDa peptide (NH 2 -LRSKSKKFRR PDIQYPDATD EDITSHMESE ELNGAYKAIP VAQD-COOH) was synthesized and purified to >97% purity by high-performance liquid chromatography (HPLC) (EZBiolabs, Westfield, IN, USA). Eight overlapping peptides span ning OPN-5 kDa were also synthesized (p1
. Lyophilized peptides were resuspended in sterile PBS and used for treatment to cells in the described invasion assays (0.4-2 mM).
Bacterial OPN-5 kDa protein expression and purification The H6-MBP-tev-OPN-5 kDa construct was transformed into BL21 Escherichia coli cells (Invitrogen) and grown in 2 L of Luria-Bertani broth at 371C, 250 r.p.m. for 2-3 h (OD 600 ¼ 0.6) before induction (1 M IPTG, 371C, 3 h, OD 600 ¼ 2.0). Cell pellets were lysed (Cellytic B, Sigma) and H6-MBP-tev-OPN-5 kDa was isolated by maltose affinity chromatography according to manufacturer's instructions (New England Biolabs, Ipswich, MA, USA). Several protein fragments were observed by SDS-PAGE analysis, one of which ran B5 kDa and reacted by Western blot with a commercial OPN antibody to the first 15 residues of the OPN-5 kDa sequence (pAb8448). Upon storage, this protein fragment was detected in increasing amounts, suggesting autocatalysis at the 6 Â histidine and Tev sites. The protein was further purified by preparative electrophoresis to >90% purity (BioRad, Hercules, CA, USA) for use as an immunogen.
Polyclonal antibody generation
The unconjugated purified OPN-5 kDa protein fragment was used for intraperitoneal immunization and antibody production in rabbits (100 mg for the primary injection, followed by 50 mg boosts at 2 and 4 weeks) (Animal Pharm Services, San
Francisco, CA, USA). Synthetic OPN-5 kDa peptide was injected for a boost immunization after 84 days (100 mg). Bleedings were conducted every 2 weeks for 6 months and immunospecific antibodies were purified using an OPN-5 kD peptide column as described below. The resulting antibody (anti-OPN-5 kDa) was evaluated using standard immunoblotting and immunoprecipitation methods.
OPN-5 kDa peptide affinity chromatography
The OPN-5 kDa synthetic peptide (5.0 mg) was reacted with 25 ml of Affigel 15 (BioRad) in 100 mM MOPS pH 7.0 at 251C for 16 h. Unreacted hydroxysuccinamide sites were blocked with 1 M ethanolamine pH 8.0 at 251C for 1 h. The peptide-conjugated slurry was poured into a 6 Â 1 0 column and was washed with 50 mM Tris pH 8.0 and 50 mM NaCl followed by 0.1 M glycine HCl pH 2.5. Washings were repeated twice and the column equilibrated to pH 8.0 with 50 mM Tris pH 8.0 and 50 mM NaCl. A total of 75 ml crude antiserum was applied to the column and subsequently washed with 50 mM Tris pH 8.0 and 50 mM NaCl. Bound antibody was eluted with 0.1 M glycine HCl pH 2.5, neutralized with 2 M Tris and concentrated by stirred cell ultrafiltration (Millipore, Billercia, MA, USA). The sample was then applied to a PBS-equilibrated HiLoad 26/60 Superdex 200 column (GE Healthcare, Piscataway, NJ, USA) and the fractions containing IgG were pooled and concentrated before measurement for protein concentration by the Bradford method (Pierce, Rockford, IL, USA).
Statistical analysis
A subset of previously published microarray data (Ye et al., 2003) was analysed using Mann-Whitney non-parametric tests. Mean and standard deviation comparisons of data collected from the invasion, migration and adhesion experiments were conducted using unpaired Student's t-tests. Quantitative RT-PCR data were also analysed using unpaired Student's t-tests.
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